Maintenance therapy for patients with advanced non-small cell lung cancer has been an
area of intense investigation. Maintenance therapy has been divided into two broad …

Maintenance chemotherapy (MC) with pemetrexed is a commonly used strategy in
nonsquamous non–small cell lung cancer. However, most of the available evidence is from …

Background Maintenance therapy for non-small cell lung cancer (NSCLC) aims to extend
disease control after first-line chemotherapy with active and well-tolerated agents. The utility …

Metastatic non-small cell lung cancer remains a disease with a high annual incidence and
annual mortality worldwide, with limitations in first-line treatment past a fixed amount of …

Maintenance therapy is emerging as a treatment strategy in the management of advanced
non small cell lung cancer (NSCLC). Initial trials addressing the question of duration of …

Nowadays, advanced non-small cell lung cancer (NSCLC) is still an incurable disease.
However, recent researches on maintenance therapy have led to considerable progress …

Introduction: The concept of maintenance therapy in lung cancer has stirred a great deal of
interest over the last decade. Several randomized studies have been conducted to find out …

Although well established for the treatment of certain hematologic malignancies,
maintenance therapy has only recently become a treatment paradigm for advanced non …

Background Recent trials have suggested that maintenance treatments improve outcomes
for patients not progressing after first-line therapy for advanced non-small-cell lung cancer …

Maintenance treatment has been intensively investigated in the field of advanced/metastatic
non-small lung cancer in order to improve outcomes in this devastating disease. Two …